Overview
Shelby D. Reed, PhD, is Professor in the Departments of Population Health Sciences and Medicine at Duke University’s School of Medicine. She is the director of the Center for Informing Health Decisions and Therapeutic Area leader for Population Health Sciences at the Duke Clinical Research Institute (DCRI). She also is core faculty at the Duke-Margolis Center for Health Policy. Dr. Reed has over 20 years of experience leading multidisciplinary health outcomes research studies. Dr. Reed has extensive expertise in designing and conducting trial-based and model-based cost-effectiveness analyses of diagnostics, drugs and patient-centered interventions. In 2016, she co-founded the Preference Evaluation Research (PrefER) Group at the DCRI, and she currently serves as its director. She and the group are frequently sought to conduct stated-preference studies to inform regulatory decisions, health policy, care delivery, value assessment and clinical decision making with applied projects spanning a wide range of therapeutic areas. She served as President for ISPOR in 2017-2018, and she currently is Past-Chair of the Society’s Health Science Policy Council.
Areas of expertise: Health Economics, Health Measurement, Stated Preference Research, Health Policy, and Health Services Research
Current Appointments & Affiliations
Recent Publications
Do Patients Think it's Worth Waiting for a Kidney? Evidence from a Discrete-Choice Experiment.
Journal Article Patient · January 2026 OBJECTIVE: Nearly 30% of kidneys from deceased donors are discarded annually in the USA. A recent study indicated that a significant number of patients would accept lower-quality kidneys to avoid long waits. We expand on previous work to assess how the dis ... Full text Link to item CiteUnlocking Patient Preferences: The Potential of Stated-Preference Methods in Clinical Decision Making.
Journal Article Value Health · January 2026 Stated-preference (SP) methods are gaining attention as tools to support patient-centered clinical decision making by quantifying individual preferences through structured tradeoffs. These methods may improve shared decision making by helping patients and ... Full text Open Access Link to item CitePreferences of BRCA mutation carriers for attributes of risk-reducing surgical options for breast and ovarian cancer.
Journal Article Cancer · November 15, 2025 BACKGROUND: Risk-reducing surgeries are the most effective strategies for cancer prevention in patients with germline pathogenic variants in the BRCA1/BRCA2 genes; these surgeries are associated with early menopause, loss of childbearing potential, and cos ... Full text Link to item CiteRecent Grants
State reproductive health policy as a determinant for maternal health
ResearchCo Investigator · Awarded by National Institutes of Health · 2025 - 2030Duke Women's Reproductive Health Research Scholars
Inst. Training Prgm or CMEMentor · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2020 - 2030DCRI D-COHRe Partnership for Innovation, Improved Access, and Operational Capability for Decentralized Clinical Trials of Medical Countermeasures in Public Health Emergencies
ResearchCo Investigator · Awarded by Biomedical Advanced Research and Development Authority · 2024 - 2029View All Grants